Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Gains from Investment Securities (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Gains from Investment Securities for 6 consecutive years, with $39.1 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 272.03% to $39.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.1 million through Dec 2025, up 271.98% year-over-year, with the annual reading at $1.1 million for FY2025, 85.76% down from the prior year.
  • Gains from Investment Securities hit $39.1 million in Q4 2025 for Protagonist Therapeutics, up from -$5000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $39.1 million in Q4 2025 to a low of -$5000.0 in Q1 2025.
  • Historically, Gains from Investment Securities has averaged $9.3 million across 4 years, with a median of $7.9 million in 2023.
  • Biggest YoY gain for Gains from Investment Securities was 462.43% in 2023; the steepest drop was 19.86% in 2023.
  • Year by year, Gains from Investment Securities stood at $1.6 million in 2022, then soared by 396.18% to $7.9 million in 2023, then skyrocketed by 32.68% to $10.5 million in 2024, then soared by 272.03% to $39.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for PTGX at $39.1 million in Q4 2025, -$5000.0 in Q1 2025, and $10.5 million in Q4 2024.